本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Aligos Therapeutics, Inc.

7.91
-0.0900-1.12%
成交量:4.78萬
成交額:38.08萬
市值:4,836.81萬
市盈率:-0.47
高:8.22
開:7.45
低:7.45
收:8.00
資料載入中...
2022/03/10

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/31

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/01/06

重要事件披露

8-K - Current report
2021/11/18

持股變動聲明

3 - Initial statement of beneficial ownership of securities
2021/11/18

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/17

SEC問詢函

CORRESP [Cover] - Correspondence
2021/06/28

SEC問詢函

CORRESP [Cover] - Correspondence
2021/06/28

SEC問詢函

CORRESP [Cover] - Correspondence
2021/06/28

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2021/06/24

重要事件披露

8-K - Current report
2021/06/24

重要事件披露

8-K/A [Amend] - Current report